Karuna Therapeutics, Inc. Research and Development Expense
Karuna Therapeutics, Inc. reported Research and Development Expense of $364.10 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-02-22
- Karuna Therapeutics, Inc. research and development expense for the quarter ending 2023-12-31 was $82.19M, a 24.53% increase year-over-year.
- Karuna Therapeutics, Inc. research and development expense for the quarter ending 2023-09-30 was $103.95M, a 67.80% increase year-over-year.
- Karuna Therapeutics, Inc. research and development expense for the quarter ending 2023-06-30 was $92.49M, a 76.22% increase year-over-year.
- Karuna Therapeutics, Inc. research and development expense for the quarter ending 2023-03-31 was $85.47M, a 95.10% increase year-over-year.
- Karuna Therapeutics, Inc. research and development expense for fiscal 2023 was $364.10M, a 62.37% increase from fiscal 2022.
- Karuna Therapeutics, Inc. research and development expense for fiscal 2022 was $224.25M, a 74.92% increase from fiscal 2021.
- Karuna Therapeutics, Inc. research and development expense for fiscal 2021 was $128.20M, a 195.34% increase from fiscal 2020.
- Karuna Therapeutics, Inc. research and development expense for fiscal 2020 was $43.41M, a 76.92% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2023-12-31 | $82.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $186.14M derived: sum of 2 quarters · filed 2024-02-22 | $278.63M derived: sum of 3 quarters · filed 2024-02-22 | $364.10M 10-K · filed 2024-02-22 |
| 2023-09-30 | $103.95M 10-Q · filed 2023-11-02 | $196.44M derived: sum of 2 quarters · filed 2023-11-02 | $281.91M 10-Q · filed 2023-11-02 | $347.91M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | $92.49M 10-Q · filed 2023-08-03 | $177.96M 10-Q · filed 2023-08-03 | $243.96M derived: sum of 3 quarters · filed 2024-02-22 | $305.91M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | $85.47M 10-Q · filed 2023-05-04 | $151.47M derived: sum of 2 quarters · filed 2024-02-22 | $213.42M derived: sum of 3 quarters · filed 2024-02-22 | $265.91M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | $66.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $127.95M derived: sum of 2 quarters · filed 2024-02-22 | $180.44M derived: sum of 3 quarters · filed 2024-02-22 | $224.25M 10-K · filed 2024-02-22 |
| 2022-09-30 | $61.95M 10-Q · filed 2023-11-02 | $114.44M derived: sum of 2 quarters · filed 2023-11-02 | $158.24M 10-Q · filed 2023-11-02 | $203.34M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $52.49M 10-Q · filed 2023-08-03 | $96.29M 10-Q · filed 2023-08-03 | $141.38M derived: sum of 3 quarters · filed 2024-02-22 | $180.16M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $43.81M 10-Q · filed 2023-05-04 | $88.90M derived: sum of 2 quarters · filed 2024-02-22 | $127.67M derived: sum of 3 quarters · filed 2024-02-22 | $151.82M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $45.09M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $83.87M derived: sum of 2 quarters · filed 2024-02-22 | $108.01M derived: sum of 3 quarters · filed 2024-02-22 | $128.20M 10-K · filed 2024-02-22 |
| 2021-09-30 | $38.77M 10-Q · filed 2022-11-03 | $62.92M derived: sum of 2 quarters · filed 2022-11-03 | $83.11M 10-Q · filed 2022-11-03 | $98.69M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $24.15M 10-Q · filed 2022-08-08 | $44.33M 10-Q · filed 2022-08-08 | $59.92M derived: sum of 3 quarters · filed 2023-02-23 | $72.50M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $20.19M 10-Q · filed 2022-05-05 | $35.77M derived: sum of 2 quarters · filed 2023-02-23 | $48.35M derived: sum of 3 quarters · filed 2023-02-23 | $59.17M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $15.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $28.17M derived: sum of 2 quarters · filed 2023-02-23 | $38.99M derived: sum of 3 quarters · filed 2023-02-23 | $43.41M 10-K · filed 2023-02-23 |
| 2020-09-30 | $12.59M 10-Q · filed 2021-11-04 | $23.40M derived: sum of 2 quarters · filed 2021-11-04 | $27.82M 10-Q · filed 2021-11-04 | $32.82M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $10.82M 10-Q · filed 2021-08-05 | $15.24M 10-Q · filed 2021-08-05 | $20.23M derived: sum of 3 quarters · filed 2022-02-24 | $26.02M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $4.42M 10-Q · filed 2021-05-06 | $9.41M derived: sum of 2 quarters · filed 2022-02-24 | $15.21M derived: sum of 3 quarters · filed 2022-02-24 | $21.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $10.79M derived: sum of 2 quarters · filed 2022-02-24 | $17.57M derived: sum of 3 quarters · filed 2022-02-24 | $24.54M 10-K · filed 2022-02-24 |
| 2019-09-30 | $5.79M 10-Q · filed 2020-11-05 | $12.58M derived: sum of 2 quarters · filed 2020-11-05 | $19.54M 10-Q · filed 2020-11-05 | $26.26M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $6.78M 10-Q · filed 2020-08-05 | $13.75M 10-Q · filed 2020-08-05 | $20.47M derived: sum of 3 quarters · filed 2021-02-25 | $21.89M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $6.97M 10-Q · filed 2020-05-07 | $13.69M derived: sum of 2 quarters · filed 2021-02-25 | $15.10M derived: sum of 3 quarters · filed 2021-02-25 | $17.28M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $8.14M derived: sum of 2 quarters · filed 2021-02-25 | $10.31M derived: sum of 3 quarters · filed 2021-02-25 | $11.54M 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.42M 10-Q · filed 2019-11-07 | $3.59M derived: sum of 2 quarters · filed 2019-11-07 | $4.82M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $2.17M 10-Q · filed 2019-08-08 | $3.40M 10-Q · filed 2019-08-08 |